CONTEXT: Report from India the the manufacturers of the Covaxin, Bharat Biotech will be conducting “Phase-4 clinical trials” to check it’s real-world effectiveness. It is probably worth noting that they Continue Reading
CONTEXT: We’ve covered reports around this theme before, so good to see further research supporting why it is important to have representative ethnic diversity in all studies on new therapies, Continue Reading
CONTEXT: A very brief update, but a potentially very important one. The FDA is convening the paediatric subcommittee to discuss how to effectively use PROs in oncology studies. We will Continue Reading
CONTEXT: I know we are preaching to the converted, but great to see the NEJM publishing a CDC study that underlines how important RWE can be in guiding decisions, even Continue Reading
CONTEXT: A very well put together and clearly well researched opinion piece promoting RWD as the basis for COVID decision making in the US. Interesting highlight of what is termed Continue Reading
CONTEXT: A proper peer reviewed study article on a retrospective study based on an oncology registry in Canada highlighting the differences in outcomes for rural versus urban patients. READ TIME: Continue Reading
IMPACT: Preliminary RWE on effectiveness of single dose of Pfizer vaccine; 1st dose of the Pfizer vaccine seen to curb infection rates by 50% within 14 days; data from 800,000 Continue Reading
IMPACT: The power of numbers…real-world data from 3.5 million vaccinated Israeli’s shows impact/ effectiveness of the Pfizer vaccine during early phase of roll out. READ TIME: 2 min *1. “Among Continue Reading
CONTEXT: Some people lost a small amount of weight whilst in a study….. Interesting thing here is the reporting of RWE data during a study lifetime, which has statistical penalties Continue Reading
CONTEXT: Real world research showing value in rare disease research where RCTs cannot generate the statistical power traditionally needed with so few available patients. New methods to interpret the RWD Continue Reading
